Medical Implications of Injection Drug Use (09HC09)

Home | Page 1 | Page 2 | Cases | References | Post-test

REFERENCES

1. SAMHSA. The National Survey on Drug Use and Health: Demographic and Geographic Variations in Injection Drug Use (2006). http://www.oas.samhsa.gov/2k7/idu/idu.htm Accessed 10/10/07.
   
   
2. Baciewicz G. Injecting Drug Use. EMedicine. June 28, 2005. http://www.emedicine.com/med/topic586.htm Accessed December 1, 2007.
   
   
3. Pieper B, Hopper JA. Injection Drug Use and Wound Care. Available at:
   Nurs Clin North Am. Volume 40, Issue 2, June 2005, Pages 349-363.
   
   
4. CDC. Cases of HIV infection and AIDS in the United States and Dependent Areas, 2005. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2005report/table9.htm
   Accessed 10/10/07.
   
   
5. NJDHSS. New Jersey HIV/AIDS Report, December 31, 2006. Available
   at: http://www.state.nj.us/health/aids/documents/qtr1206.pdf
   Accessed 10/10/07.
   
   
6. MayoClinic. Infectious Diseases, Hepatitis C. Available at:
   http://www.mayoclinic.com/health/hepatitis-c/DS00097
   Accessed 10/10/07.
   
   
7. CDC. Surveillance for acute viral hepatitis–United States 2005. MMWR
   March 16 2007, 56, No SS3, pp 1-24. Available at:
   http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5603a1.htm
   Accessed 10/10/07.
   
   
8. Armstrong GL,Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter
   MJ. The prevalence of hepatitis C virus infection in the United States,
   1999 through 2002. Ann Intern Med. 2006;144:705-714. Available at
   http://www.annals.org/content/vol144/issue10 Accessed 10/10/07.
   
   
9. CDC. Disease Burden from Hepatitis A, B, C in the United States,
   Viral Hepatitis Surveillance. Available at:
   http://www.cdc.gov/ncidod/diseases/hepatitis/resource/dz_burden.htm
   Accessed 10/10/07.
   
   
10. Sulkowski MS. Hepatitis C virus infection in HIV-infected patients.
    Curr HIV/AIDS. Rep. 2004 Sep;1(3):128-35. Available at:
    http://lib.bioinfo.pl/pmid:16091233 Accessed 11/20/07.
    
    
11. MayoClinic. Infectious Diseases, Hepatitis B. Available at
    http://www.mayoclinic.com/health/hepatitis-b/DS00398
    Accessed 10/12/07.
    
    
12. Summanen PH, Talan DA, Strong C, McTeague M, Bennion R,
    Thompson JE jr, Vaisanen ML, Moran G, Winer M, Finegold SM.
    Bacteriology of skin and soft tissue infections: comparison of
    infections in intravenous drug users and individuals with no
    history of intravenous drug use. Clin Infect Dis. 1995; 20
    (Suppl 2): S279-82.
    
    
13. Tuazon CU, Sheagren JN: Increased rate of carriage of
    staphylococcus aureus among narcotic addicts. J Infect Dis.
    1974; 129: 725-727.
    
    
14. Charlebois ED, Bangsberg DR, Moss NJ, Moore MR, Moss AR,
    Chambers HF, Perdreau-Remington F. Population based community
    prevalence of methicillin resistant Staphylococcus aureus in the urban
    poor of San Francisco. Clin Infect Dis. 2002, Feb 15 1; 34(4): 425-33.
    
    
15. Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR.
    High prevalence of abscesses and cellulitis among community
    recruited injection drug users in San Francisco. Clin Infect Dis.
    2000, 30;579-81.
    
    
16. Kak V, Chandrasekar PH Bone and joint infections in injection drug
    users. Infect Dis Clin North Am. 2002 Sep; 16 (3): 681-95.
    
    
17. Spijkerman IJ, van Ameijden EJ, Mientjes GH, Coutinho RA,
    van der Hoek A. Human immunodeficiency virus infection and
    other risk factors for skin abscesses and endocarditis among
    injection drug users. J Clin Epid. 1996; 49: 1149-54.
    
    
18. Vlahov D, Sullivan M, Astemborski J, Nelson KE. Bacterial infections
    and skin cleaning prior to injection among intravenous drug users.
    Public Health Rep. 1992; 107:595-8.
    
    
19. Stein MD. Medical complications of intravenous drug use
    J Gen Intern Med. 1990;5:249-57.
    
    
20. Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH,
    Edlin BR. Risk factors for skin and soft-tissue abscesses among
    injection drug users: a case-control study. Clin Infect Dis. 2001
    Jul 1;33(1):35-40.
    
    
21. US Department of Health and Human Services, Office of Disease
    Prevention and Health Promotion. Healthy People 2010 Progress
    Review: Immunization and Infectious Diseases. July 20, 2007.
    Available at: http://www.healthypeople.gov/data/2010prog/focus14
    Accessed December 19, 2007.
    
    
22. Piper TM, Rudenstine S, Stancliff S, Sherman S, Nandi V, Clear A,
    Galea S. Overdose prevention for injection drug users: lessons
    learned from naloxone training and distribution programs in
    New York City. Harm Reduct J. 2007 Jan 25;4:3. Available at:
    http://www.harmreductionjournal.com/content/4/1/3
    Accessed December 19, 2007.